HIV and viral hepatitis disclosure [in South Australia] – factsheet

SA Health, updated 2019

Deciding to disclose your HIV or viral hepatitis (hepatitis B or hepatitis C) status is a personal choice. There are few situations where you are legally required to disclose your HIV or viral hepatitis status, however, there may be times when it’s in your best interests to disclose your status even if you are not legally required to do so.

 

‘Lets Talk About It’: South Australian Sexual Health Survey Results 2019

SAHMRI & Flinders University,  4th October, 2019

A South Australian-first youth sexual health survey has provided a unique snapshot of the sexual behaviours and knowledge of the state’s young people. 

The head of SAHMRI’s Sexual Health and Wellbeing program, Associate Professor James Ward, says the results will help design policies, health services and education programs aimed at reducing sexually transmitted infections (STIs), HIV and viral hepatitis (BBVs).

 

 

HIV & Sexual Health Update for Nurses and Aboriginal Health Workers in South Australia

Adelaide Sexual Health Centre , October 2019

Adelaide Sexual Health Centre presents Stepping Out: Living Healthy & Long, an HIV & Sexual Health Update for Nurses and Aboriginal Health Workers in South Australia.

With the generous support of an unconditional education grant from ViiV Healthcare, ASHC is able to provide a seminar at no cost to the participant, hosted in central Adelaide with reduced rate car parking next door.

Participants will enjoy an update on sexual health, HIV and Hepatitis with speakers from Adelaide Sexual Health Centre as well as key health partners.

The attached flyer (below) details the event and the sponsor, and the final programme will be posted shortly.

Participants must register to attend. This allows the organisers to manage catering etc.

When: Saturday 6th Nov, 930 am – 2 pm

Where: Pullman Hotel, 16 Hindmarsh Square Adelaide

Cost: Free

Striving towards the elimination of HCV infection among PWID

International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019)

Nearly 200 pages of open access articles from projects and research around the world.

While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where elimination hopes and potentials are less clear, such as in many low and middle income countries. Strengthening capacity in areas of the world where resources are more limited will be a critical step towards ensuring equity for all so that global HCV elimination among PWID can be achieved.

  • Browse articles here
  • You can also download the full issue as PDF by creating an account and signing in at the above link

In contrast to Australia’s success with hepatitis C, our response to hepatitis B is lagging

The Conversation, October 15th, 2019

Around one-third of Australians living with hepatitis C have been cured in the last four years. Australia’s response to hepatitis C is seen as a leading example around the world, and the elimination of the disease as a major public health threat is looking like an increasingly achievable goal.

But the situation is much less promising for Australians living with hepatitis B, which is now the most common blood-borne viral infection in Australia. It affects more people than hepatitis C and HIV combined.

Medicare ineligible PLHIV in Australia

NAPWHA, May 2019

This NAPWHA report is an analysis drawing together several years’ worth of data from the main pharmaceutical industry suppliers of compassionate access antiretroviral (ARV) therapy in Australia and combines this with, for the first time, data from the State and Territory jurisdictions to produce the most accurate estimate to-date of the number of Medicare ineligible PLHIV in Australia. It comes with recommendations for systemic improvements.